Home › Funds › Renaissance Technologies › PRLD
Renaissance Technologies position in PRLD
PRELUDE THERAPEUTICS INC · Health Care
Latest position (Q2 2026)281.20K sh
Reported value held$1.50M
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 127.20K | $1.58M | New |
| Q1 2022 | 40.10K | $277.00K | Reduce |
| Q2 2022 | 160.49K | $838.00K | Add |
| Q3 2022 | 143.40K | $948.00K | Reduce |
| Q4 2022 | 136.50K | $824 | Reduce |
| Q1 2023 | 138.50K | $789 | Add |
| Q2 2023 | 183.30K | $825 | Add |
| Q3 2023 | 139.37K | $431 | Reduce |
| Q4 2023 | 216.40K | $924 | Add |
| Q1 2024 | 244.80K | $1.16K | Add |
| Q2 2024 | 206.60K | $787.15K | Reduce |
| Q3 2024 | 196.90K | $407.58K | Reduce |
| Q4 2024 | 634.50K | $808.99K | Add |
| Q1 2025 | 656.70K | $504.35K | Add |
| Q1 2025 | 656.70K | $504.35K | Add |
| Q2 2025 | 581.80K | $470.91K | Reduce |
| Q2 2025 | 581.80K | $470.91K | Reduce |
| Q3 2025 | 544.00K | $783.36K | Reduce |
| Q4 2025 | 271.30K | $786.77K | Reduce |
| Q1 2026 | 275.20K | $941.18K | Add |
| Q2 2026 | 281.20K | $1.50M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PRLD
- BlackRock Inc 1.80M sh · $9.58M · Q2 2026
- Two Sigma Investments 993.37K sh · $5.29M · Q2 2026
- Millennium Management 844.99K sh · $4.50M · Q2 2026
- Geode Capital Management 841.86K sh · $4.49M · Q2 2026
- Vanguard Group 1.41M sh · $4.10M · Q4 2025
- Morgan Stanley 503.86K sh · $2.69M · Q2 2026
- UBS Group AG 318.80K sh · $1.70M · Q2 2026
- Northern Trust Corp 240.60K sh · $1.28M · Q2 2026
- Marshall Wace 190.69K sh · $1.02M · Q2 2026
- Goldman Sachs Group 120.83K sh · $644.04K · Q2 2026
- BNY Mellon 68.19K sh · $363.44K · Q2 2026